Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

EMCURE PHARMACEUTICALS LTD.

NSE : EMCUREBSE : 544210ISIN CODE : INE168P01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE1395.15-9.1 (-0.65 %)
PREV CLOSE () 1404.25
OPEN PRICE () 1381.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2844
TODAY'S LOW / HIGH ()1381.20 1417.85
52 WK LOW / HIGH ()890 1524.85
NSE1396.20-7.3 (-0.52 %)
PREV CLOSE() 1403.50
OPEN PRICE () 1395.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 122772
TODAY'S LOW / HIGH() 1385.00 1404.00
52 WK LOW / HIGH ()889 1519.9
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1981

Management Info :

Berjis Desai - Chairman Satish Mehta - Managing Director

Registered Office :

Address : Plot No. P-1 & P-2,I T - B T Park, Phase- I I,M I D C, Hinjawadi,
Pune,
Maharashtra-411057

Phone : 020-35070033 / 35070000

Website : www.emcure.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
27Nov Emcure Pharmaceuticals informs about d
Emcure Pharmaceuticals has informed that it enclosed the disclosure rega..
22Nov Emcure Pharmaceuticals informs about r
Emcure Pharmaceuticals has informed that Mr. Chetan Sharma (FCS:8352) ha..
19Nov Emcure Pharmaceuticals informs about
In continuation to letter dated November 14, 2025 and pursuant to the pr..
10Nov Emcure Pharma, Novo Nordisk India join
Emcure Pharmaceuticals and Novo Nordisk India have entered into a strate..
06Oct Emcure Pharmaceuticals surges on acqui
Emcure Pharmaceuticals is currently trading at Rs. 1398.35, up by 58.05..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit1176.223171.28
Gross Profit 1578.91 4277.1
Operating Profit 2473.447656.44
Net Sales 12606.0443819.24
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Alkem Laboratories (BSE)
 5689.30 (1.38%)
M.Cap ( in Cr)
68024.12
Abbott India (BSE)
 28869.35 (0.15%)
M.Cap ( in Cr)
61345.35
Glaxosmithkline Phar (BSE)
 2543.10 (1.35%)
M.Cap ( in Cr)
43081.65
Wockhardt (BSE)
 1360.10 (2.16%)
M.Cap ( in Cr)
22100.56
RPG Life Sciences (BSE)
 2228.80 (1.27%)
M.Cap ( in Cr)
3686.22
Shareholding Pattern
PROMOTERS 77.88%
NON-INSTITUTION 14.46%
MUTUAL FUNDS/UTI 3.58%
FI/BANKS/INSURANCE 0.49%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX85712.37447.05 (0.52%)
NIFTY26186.45152.70 (0.59%)
Dow Jones 47954.99104.05 (0.22%)
Nasdaq 23578.1372.99 (0.31%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI